Fintel reports that on September 5, 2025, Truist Securities initiated coverage of Revolution Medicines (BIT:1RVMD) with a Buy recommendation.

What is the Fund Sentiment?

There are 687 funds or institutions reporting positions in Revolution Medicines. This is an increase of 33 owner(s) or 5.05% in the last quarter. Average portfolio weight of all funds dedicated to 1RVMD is 0.49%, an increase of 27.69%. Total shares owned by institutions decreased in the last three months by 7.20% to 209,825K shares.

What are Other Shareholders Doing?

Farallon Capital Management holds 14,326K shares representing 7.66% ownership of the company. In its prior filing, the firm reported owning 13,535K shares , representing an increase of 5.52%. The firm decreased its portfolio allocation in 1RVMD by 14.78% over the last quarter.

Janus Henderson Group holds 10,591K shares representing 5.67% ownership of the company. In its prior filing, the firm reported owning 10,190K shares , representing an increase of 3.78%. The firm decreased its portfolio allocation in 1RVMD by 68.88% over the last quarter.

Wellington Management Group Llp holds 10,260K shares representing 5.49% ownership of the company. In its prior filing, the firm reported owning 11,788K shares , representing a decrease of 14.89%. The firm decreased its portfolio allocation in 1RVMD by 88.01% over the last quarter.

Baker Bros. Advisors holds 9,365K shares representing 5.01% ownership of the company. In its prior filing, the firm reported owning 7,937K shares , representing an increase of 15.25%. The firm increased its portfolio allocation in 1RVMD by 7.62% over the last quarter.

Nextech Invest holds 7,601K shares representing 4.07% ownership of the company. No change in the last quarter.